Daiichi Sankyo (OTCMKTS:DSNKY) Trading Down 2.1%

view original post

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Rating) fell 2.1% during mid-day trading on Friday . The company traded as low as $25.38 and last traded at $25.60. 49,973 shares changed hands during trading, a decline of 58% from the average session volume of 119,942 shares. The stock had previously closed at $26.14.

The firm’s 50 day moving average price is $25.30 and its 200-day moving average price is $23.55.

About Daiichi Sankyo (OTCMKTS:DSNKY)

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer’s disease; and laninamivir for anti-influenza treatment.

Featured Articles

Receive News & Ratings for Daiichi Sankyo Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Daiichi Sankyo and related companies with MarketBeat.com’s FREE daily email newsletter.